VANGUARD has selected five companies for up to $200,000 in non-dilutive funding contracts and 10 companies for the 2025 ...

Advancing novel programs for respiratory viruses that pose pandemic threats or risk of serious illness, including SARS CoV2 ...

The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...

WHO has recognised mental health and, more recently, brain health as public health priorities.1 This momentum was further advanced at the National, Regional and International Plans for Brain and ...

HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door ...

It ain’t what you don’t know that gets you into trouble. It’s what you know for sure that just ain’t so.” Mark Twain’s quip ...

National Institutes of Health Director Jay Bhattacharya claims the federal government recently cancelled millions of dollars’ ...

Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage trial, joining multiple biotech companies that have lost government funding for their ...

Trump officials are capitalizing on lingering COVID resentment to undermine American vaccine policy.

HealthSecretary Robert F. Kennedy Jr. has defunded research in messenger RNA vaccines, which could jeopardize efforts to ...